These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34980759)

  • 21. Effect of coronavirus disease 2019 pandemic on the lifestyle and glycemic control in patients with type 2 diabetes: a cross-section and retrospective cohort study.
    Munekawa C; Hosomi Y; Hashimoto Y; Okamura T; Takahashi F; Kawano R; Nakajima H; Osaka T; Okada H; Majima S; Senmaru T; Nakanishi N; Ushigome E; Hamaguchi M; Yamazaki M; Fukui M
    Endocr J; 2021 Feb; 68(2):201-210. PubMed ID: 32999133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of COVID-19 Lockdown on the Incidence of Type 1 DM and the Glycemic Control of Diabetic Children: Findings from a Teaching Hospital, Saudi Arabia.
    Al-Qahtani MH; Bukhamseen FM; Al-Qassab AT; Yousef AA; Awary BH; Albuali WH; Alkhalifa ZM; Yousef HA
    Rev Diabet Stud; 2022 Sep; 18(3):152-156. PubMed ID: 36309774
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of the COVID-19 pandemic on metabolic control in children with type 1 diabetes: a single-center experience.
    Sarıkaya E; Çiçek D; Gök E; Kara L; Berber U; Şiraz ÜG; Kendirci M; Hatipoğlu N
    J Pediatr Endocrinol Metab; 2022 Feb; 35(2):191-195. PubMed ID: 34561974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lifestyle changes as a result of COVID-19 containment measures: Bodyweight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency.
    Tanaka N; Hamamoto Y; Kurotobi Y; Yamasaki Y; Nakatani S; Matsubara M; Haraguchi T; Yamaguchi Y; Izumi K; Fujita Y; Kuwata H; Hyo T; Yamada Y; Kurose T; Seino Y
    J Diabetes Investig; 2021 Sep; 12(9):1718-1722. PubMed ID: 33599073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of COVID-19 lockdown on glycemic control in type 1 diabetes.
    Duarte V; Mota B; Ferreira S; Costa C; Correia CC
    Arch Pediatr; 2022 Jan; 29(1):27-29. PubMed ID: 34955306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of COVID-19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study.
    Bouchi R; Sugiyama T; Goto A; Ohsugi M; Yoshioka N; Katagiri H; Mita T; Hirota Y; Ikegami H; Matsuhisa M; Araki E; Yokoyama H; Minami M; Yamazaki K; Jinnouchi H; Ikeda H; Fujii H; Nogawa M; Kaneshige M; Miyo K; Ueki K
    J Diabetes Investig; 2023 Aug; 14(8):994-1004. PubMed ID: 37183588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the COVID-19 pandemic on glycemic control in Brazilian patients with type 2 diabetes.
    Tannus LRM; Zapelini RM; Cabizuca CA; Abi-Abib RC; Matheus ASM; Calassara PC; Pozzan R; Cobas RA
    Endocrine; 2022 Sep; 77(3):455-460. PubMed ID: 35838896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and predictors of suboptimal glycemic control among patients with type 2 diabetes mellitus in northern Thailand: A hospital-based cross-sectional control study.
    Yeemard F; Srichan P; Apidechkul T; Luerueang N; Tamornpark R; Utsaha S
    PLoS One; 2022; 17(1):e0262714. PubMed ID: 35041704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus.
    Verma A; Rajput R; Verma S; Balania VKB; Jangra B
    Diabetes Metab Syndr; 2020; 14(5):1213-1216. PubMed ID: 32679527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploratory study on glycemic control improvement for patients with diabetes mellitus by appropriate re-education on insulin self-injection technique during COVID-19 pandemic.
    Honjo S; Koshii Y; Tozaka S; Tateno H; Keidai Y; Seno Y; Iwasaki Y; Iwasaki K; Ayano S; Hamasaki A
    Diabetes Res Clin Pract; 2023 Jan; 195():110192. PubMed ID: 36544290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic.
    Ruissen MM; Regeer H; Landstra CP; Schroijen M; Jazet I; Nijhoff MF; Pijl H; Ballieux BEPB; Dekkers O; Huisman SD; de Koning EJP
    BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33431602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time trends (2012-2020) in glycated hemoglobin and adherence to the glycemic targets recommended for elderly patients by the Japan Diabetes Society/Japan Geriatrics Society Joint Committee among memory clinic patients with diabetes mellitus.
    Sugimoto T; Noma H; Kuroda Y; Matsumoto N; Uchida K; Kishino Y; Saji N; Niida S; Sakurai T
    J Diabetes Investig; 2022 Dec; 13(12):2038-2046. PubMed ID: 36124721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying Worsened Glycemic Control During the COVID-19 Pandemic.
    Ledford CJW; Roberts C; Whisenant E; Walters C; Akamiro K; Butler J; Ali A; Seehusen DA
    J Am Board Fam Med; 2021 Feb; 34(Suppl):S192-S195. PubMed ID: 33622837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus.
    Sussman JB; Kerr EA; Saini SD; Holleman RG; Klamerus ML; Min LC; Vijan S; Hofer TP
    JAMA Intern Med; 2015 Dec; 175(12):1942-9. PubMed ID: 26502220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes mellitus in chronic kidney disease: Biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortality.
    Copur S; Onal EM; Afsar B; Ortiz A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    J Diabetes Complications; 2020 Nov; 34(11):107707. PubMed ID: 32861562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database.
    Okada A; Yamaguchi S; Ono S; Kurakawa KI; Yasunaga H; Nangaku M; Yamauchi T; Kadowaki T
    J Diabetes Investig; 2024 Jul; 15(7):953-963. PubMed ID: 38429979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycemic Control, Renal Progression, and Use of Telemedicine Phone Consultations Among Japanese Patients With Type 2 Diabetes Mellitus During the COVID-19 Pandemic: Retrospective Cohort Study.
    Sankoda A; Nagae Y; Waki K; Sze WT; Oba K; Mieno M; Nangaku M; Yamauchi T; Ohe K
    JMIR Diabetes; 2023 Nov; 8():e42607. PubMed ID: 37315193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with the degree of glycemic deterioration among patients with type 2 diabetes who dropped out of diabetes care: A longitudinal analysis using medical claims and health checkup data in Japan.
    Ihana-Sugiyama N; Sugiyama T; Imai K; Yanagisawa-Sugita A; Tanaka H; Ohsugi M; Ueki K; Tamiya N; Kobayashi Y
    J Diabetes Investig; 2022 Mar; 13(3):571-579. PubMed ID: 34599560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of COVID-19 lockdown on glycaemic control and lifestyle changes in children and adolescents with type 1 and type 2 diabetes mellitus.
    Cheng HP; Wong JSL; Selveindran NM; Hong JYH
    Endocrine; 2021 Sep; 73(3):499-506. PubMed ID: 34244903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of SARS-CoV-2 Infection and Infection Severity on Longer-Term Glycemic Control and Weight in People With Type 2 Diabetes.
    Wong R; Vaddavalli R; Hall MA; Patel MV; Bramante CT; Casarighi E; Johnson SG; Lingam V; Miller JD; Reusch J; Saltz M; Stürmer T; Tronieri JS; Wilkins KJ; Buse JB; Saltz J; Huling JD; Moffitt R;
    Diabetes Care; 2022 Nov; 45(11):2709-2717. PubMed ID: 36098660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.